
    
      The study will comprise of a medical Screening visit, two 2-night (3-day) Treatment Periods,
      2 outpatient visits, and a Follow-up visit. Each Treatment visit will be separated by a
      washout of up to 7 days. The Follow-up visit will occur approximately 7 days (Â±1) following
      the last study drug administration. The duration of subject participation, including
      screening, will be approximately 8 weeks.
    
  